6JDV image
Entry Detail
PDB ID:
6JDV
Title:
Crystal structure of Nme1Cas9 in complex with sgRNA and target DNA (ATATGATT PAM) in catalytic state
Biological Source:
PDB Version:
Deposition Date:
2019-02-02
Release Date:
2019-11-06
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CRISPR-associated endonuclease Cas9
Mutations:H588A
Chain IDs:A
Chain Length:1083
Number of Molecules:1
Biological Source:Neisseria meningitidis serogroup C (strain 8013)
Polymer Type:polyribonucleotide
Description:sgRNA
Chain IDs:B
Chain Length:147
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Description:target DNA strand
Chain IDs:C
Chain Length:35
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Description:non-target DNA strand
Chain IDs:D
Chain Length:11
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
Mol.Cell 76 938 ? (2019)
PMID: 31668930 DOI: 10.1016/j.molcel.2019.09.025

Abstact

High-resolution Cas9 structures have yet to reveal catalytic conformations due to HNH nuclease domain positioning away from the cleavage site. Nme1Cas9 and Nme2Cas9 are compact nucleases for in vivo genome editing. Here, we report structures of meningococcal Cas9 homologs in complex with sgRNA, dsDNA, or the AcrIIC3 anti-CRISPR protein. DNA-bound structures represent an early step of target recognition, a later HNH pre-catalytic state, the HNH catalytic state, and a cleaved-target-DNA-bound state. In the HNH catalytic state of Nme1Cas9, the active site is seen poised at the scissile phosphodiester linkage of the target strand, providing a high-resolution view of the active conformation. The HNH active conformation activates the RuvC domain. Our structures explain how Nme1Cas9 and Nme2Cas9 read distinct PAM sequences and how AcrIIC3 inhibits Nme1Cas9 activity. These structures provide insights into Cas9 domain rearrangements, guide-target engagement, cleavage mechanism, and anti-CRISPR inhibition, facilitating the optimization of these genome-editing platforms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures